Regulatory 2020-08-20 | Quarterly Report Q2-2020: First participant in the hepatic study PDF Report Presentation Webcast
Regulatory 2020-07-31 | Change in number of shares and votes in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2020-06-30 | Ascelia Pharma completes a directed new share issue of 4,697,781 shares, raising approximately SEK 98.7 million PDF Report Presentation Webcast
2020-06-09 | Presentation of Ascelia Pharma at ABGSC Life Science Summit Day and Redeye Orphan Drug Day PDF Report Presentation Webcast
2020-05-26 | Vator Securities: Ascelia Pharma: A delay. Fundamentals for Mangoral remain unchanged. PDF Report Presentation Webcast
Regulatory 2020-05-20 | Updated SPARKLE timelines due to Covid-19 impact PDF Report Presentation Webcast
Regulatory 2020-05-13 | Interim Financial Report Q1-2020: First patient enrolled in Phase 3 study SPARKLE PDF Report Presentation Webcast
Regulatory 2020-05-06 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 6 May 2020 PDF Report Presentation Webcast
Regulatory 2020-05-06 | First participant enrolled in the clinical hepatic impairment study with Mangoral PDF Report Presentation Webcast
Regulatory 2020-04-06 | Ascelia Pharma publishes Annual Report for the financial year 2019 PDF Report Presentation Webcast
Regulatory 2020-04-03 | Ascelia Pharma’s Nomination Committee proposes election of Lauren Barnes to the Board of Directors PDF Report Presentation Webcast
Regulatory 2020-04-03 | NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB PDF Report Presentation Webcast
Regulatory 2020-04-01 | Correction to press release regarding in change in number of shares and votes in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2020-03-31 | Change in number of shares and votes in Ascelia Pharma AB PDF Report Presentation Webcast
2020-03-05 | Analysguiden/Carlsquare updates its view on Ascelia Pharma and raises target share price PDF Report Presentation Webcast